Biora Therapeutics, Inc. (BIOR)
| Market Cap | 154.65M |
| Revenue (ttm) | 1.19M |
| Net Income (ttm) | -228.96M |
| Shares Out | 184.20M |
| EPS (ttm) | -2.57 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,229,550 |
| Open | 0.813 |
| Previous Close | 0.848 |
| Day's Range | 0.800 - 0.875 |
| 52-Week Range | 0.630 - 6.200 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 10, 2022 |
About BIOR
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, including PGN-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis; and PGN-001, an orally delivered variant of adalimumab for the treatment of ulcerative colitis. It also develops systemic oral delivery of biotherapeutics, which include PGN-OB, a combination product of a variant of adalimumab and the Oral Biot...
Financial Performance
In 2021, BIOR's revenue was $1.25 million, an increase of 669.75% compared to the previous year's $162,000. Losses were -$247.41 million, 28.5% more than in 2020.
Financial StatementsNews
Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform
Marks 29 Patents Worldwide Directed to Biora's Device Localization Technology Marks 29 Patents Worldwide Directed to Biora's Device Localization Technology
Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the Company's management team will be pres...
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
Completed transformation with the launch of Biora Therapeutics to reflect the company's focus on oral therapeutic solutions
BIOR Stock Starts Trading as Progenity's Rebrand Takes Shape. What to Know.
Biora's product is supposed to enable biologics to be delivered directly to GI tracts. BIOR stock is a favorite of retail investors.
Progenity Announces Successful Transfer of Liquid Biopsy Technologies
Enumera Molecular Formed to Develop and Commercialize Next-Generation Solutions for Liquid Biopsy Enumera Molecular Formed to Develop and Commercialize Next-Generation Solutions for Liquid Biopsy
Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.
SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG) today announced that it will report first quarter ended March 31, 2022 financial results on Tuesday, May 10, 2022 after the clo...
Progenity Appoints Paul Shabram to Lead Technical Operations of the Company's Ingestible Drug/Device Platforms
Expanding Leadership Team to Accelerate Development of Innovative Therapeutic Delivery Platforms Expanding Leadership Team to Accelerate Development of Innovative Therapeutic Delivery Platforms
Progenity to Become Biora Therapeutics as it Completes Transformation
Upcoming Change Reflects the Company's Focus on Oral Delivery of Biotherapeutics Upcoming Change Reflects the Company's Focus on Oral Delivery of Biotherapeutics
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announ...
Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Accelerated Company Transformation Toward Oral Delivery of Biotherapeutics and Targeted Therapeutics Programs
Should You Invest in These Penny Stocks Next Month? 3 to Watch
Will these penny stocks be on your watchlist in April? The post Should You Invest in These Penny Stocks Next Month?
Penny Stocks To Buy Now? 4 Short Squeeze Stocks To Watch This Week
Short squeeze stocks to watch this week. The post Penny Stocks To Buy Now?
Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update
SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announ...
Progenity Progresses its Drug Delivery System Clinical Device Performance Studies
Clinical Device Performance Study in Healthy Volunteers Demonstrated Accurate Localization and Delivery
Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announc...
Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO'22
Patient data establishes key correlations for therapeutic exposure in tissue and alternative inflammatory pathways, supporting the hypotheses of targeted therapeutic delivery and potential combination t...
Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
Dr. Bram Verstockt presented key patient data establishing correlation between drug levels in colon and clinical outcomes Dr. Bram Verstockt presented key patient data establishing correlation between d...
Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February
Here's three penny stocks that investors are watching rig The post Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...
Top Reddit Penny Stocks That Investors Are Watching Right Now
Reddit penny stocks are heating up, here's three to know about The post Top Reddit Penny Stocks That Investors Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information |...
3 Penny Stocks Climbing During Today's Trading Session
These penny stocks climbed today, here's what you need to know The post 3 Penny Stocks Climbing During Today's Trading Session appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...
These 4 Penny Stocks Exploded Today, Here's Why
These penny stocks climbed today, here's what you need to know The post These 4 Penny Stocks Exploded Today, Here's Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Here's 3 Trending Penny Stocks to Add to Your Watchlist in February
Check these trending penny stocks out for your watchlist The post Here's 3 Trending Penny Stocks to Add to Your Watchlist in February appeared first on Penny Stocks to Buy, Picks, News and Information |...
Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional Patent
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the award of another new patent related to its single-molecule detection...
5 Top Penny Stocks To Buy Now According To Reddit
5 Reddit penny stocks to watch right now. The post 5 Top Penny Stocks To Buy Now According To Reddit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Can These Penny Stocks Climb This Week? 4 To Watch Right Now
Are these penny stocks on your watchlist for next week? The post Can These Penny Stocks Climb This Week?